Findings

Hard ticks (Ixodidae) are the main vectors of the spotted fever Rickettsiae in humans, a group of diseases that is be caused by approximately 20 different Rickettsia species of which one-third circulate in Europe [1]. Recently, van Overbeek and colleagues reported the presence of Rickettsia australis in I. ricinus ticks [2]. They successfully amplified the 16S rRNA gene from DNA extracts from ticks derived from three natural areas in the Netherlands. Sequences of some fragments matched best with R. australis (99% similarity), and therefore the authors concluded that they identified R. australis. They found 28 ticks positive for the sequence, and reported that the prevalence of R. australis varied between 6.7 and 33% in the investigated areas. This finding struck us as remarkable as it would be the first description of this pathogen in Europe. R. australis is the etiologic agent of Queensland tick typhus, a disease that normally occurs along the eastern coast of Australia, including Queensland. Clinical features that may be present include fever, headache, myalgia and an eschar at the site of the tick bite. A maculopapular or vesicular skin rash is frequently noted. Patients usually make an uncomplicated recovery, but severe to fatal outcomes have been attributed to R. australis infection as well [3]. Thus, the presence of R. australis in Europe could have significant public health consequences.

This publication was noted by Lyme patients' associations in The Netherlands and they promptly discussed these findings on their websites (http://www.borreliose.nl/; http://www.lymevereniging.nl/). At our institute, ticks from various sources are routinely tested for potential pathogens [4–7], but during the last decade, we never detected R. australis- positive ticks. R. helvetica, on the other hand, was found in ticks from every studied location with a prevalence varying from 6 to 67% (~ 6000 ticks). This raised the question how this obvious discrepancy between our results could be explained.

We therefore re-examined the original sequence data of the van Overbeek study, which covered the last 450 bp of the 16S rRNA gene by comparison to sequences of R. helvetica [GenBank:L36212] and R. australis [GenBank:L36101] published in GenBank (Figure 1). These sequences contained 4 and 7 nucleotide changes compared to the matching target sequences of R. helvetica and R. australis, respectively. Next, a fraction of the DNA samples of ticks from their study were re-examined with our PCR-amplification protocol followed by Reverse Line Blot (RLB) as described earlier [7]. In theory, our PCR protocol using generic 16S rRNA primers for Rickettsiae would be able to amplify R. australis DNA (not shown). The PCR products of these samples hybridized with the R. helvetica RLB probe. The PCR-products were sequenced on both strands, and turned out to be 100% identical to the published R. helvetica ([GenBank:L36212]; Figure 1). For confirmation, part of the ompB gene was amplified (729 bp) as an independent marker and sequenced. The sequence was 100% identical to the corresponding ompB gene sequence of R. helvetica [GenBank:AF123725] and was only 38.9% similar to R. australis [GenBank:AF123709]. Thus, we could not detect R. australis in the DNA samples of the previous study. Instead, we have strong indications that R. helvetica was misidentified as R. australis because of a combination of sequencing errors and usage of a limited set of reference sequences.

Figure 1
figure 1

Comparison of sequences from tick lysates with reference sequence. 16S rRNA gene sequences from Genbank (R. australis: L36101, R. helvetica: L36212) were aligned with sequences from the Van Overbeek study (v.Overbeek) and with the sequence we obtained from their samples (Tijsse).

Full size image